Yesterday we learned that OneDrop had acquired the asset of Sano, one of the many failed Dexcom wannabes. According to a story on the Hit Consultant website;
“One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano’s continuous glucose sensing platform.
One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.”
Now for those unfamiliar with OneDrop it’s one of the many Livongo wannabes. (Not to digress any but have you . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.